|
|
| Product Name: | TD 139 | | Synonyms: | TD 139;3,3'-dideoxy-3,3'-di-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1'-surfanediyl-di-D-galactopyranoside;CS-2525;TD-139; TD 139;β-D-Galactopyranoside, 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-β-D-galactopyranosyl 3-deoxy-3-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-;(2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol);33DFTG | | CAS: | 1450824-22-2 | | MF: | C28H30F2N6O8S | | MW: | 648.64 | | EINECS: | | | Product Categories: | | | Mol File: | 1450824-22-2.mol |  |
| | TD 139 Chemical Properties |
| Boiling point | 1017.2±75.0 °C(Predicted) | | density | 1.76±0.1 g/cm3(Predicted) | | pka | 12.33±0.70(Predicted) | | form | Solid | | color | White to off-white |
| | TD 139 Usage And Synthesis |
| Uses | TD 139 is used as a galactoside inhibitors of galectins, suitable for treating pulmonary fibrosis; such as idiopathic pulmonary fibrosis in mammals. |
| | TD 139 Preparation Products And Raw materials |
|